Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Breast cancer

Implication of Pre- and Post-radiotherapy ctDNA Dynamics in Patients with Residual Triple-Negative Breast Cancer at Surgery after Neoadjuvant Chemotherapy: Findings from a Prospective Observational Study

Tae Hoon Lee, Haeyoung Kim, Yeon Jeong Kim, Woong-Yang Park, Won Park, Won Kyung Cho, Nalee Kim

Cancer Res Treat. 2024;56(2):531-537. Published online November 10, 2023 DOI: https://doi.org/10.4143/crt.2023.996

Lung and Thoracic cancer

Revolutionizing Non–Small Cell Lung Cancer Diagnosis: Ultra-High-Sensitive ctDNA Analysis for Detecting Hotspot Mutations with Long-term Stored Plasma

Ji-Young Lee, Seyeon Jeon, Ha Ra Jun, Chang Ohk Sung, Se Jin Jang, Chang-Min Choi, Sung-Min Chun

Cancer Res Treat. 2024;56(2):484-501. Published online October 23, 2023 DOI: https://doi.org/10.4143/crt.2023.712

Hematologic malignancy

Circulating Tumor DNA Reflects Histologic and Clinical Characteristics of Various Lymphoma Subtypes

Jin Ju Kim, Hye Min Kim, Hongkyung Kim, Soo-Jeong Kim, Seung-Tae Lee, Jong Rak Choi, Saeam Shin, Doh Yu Hwang

Cancer Res Treat. 2024;56(1):314-323. Published online July 17, 2023 DOI: https://doi.org/10.4143/crt.2023.667

Genitourinary cancer

Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer

Xiaochen Fei, Xinxing Du, Yiming Gong, Jiazhou Liu, Liancheng Fan, Jiayi Wang, Yanqing Wang, Yinjie Zhu, Jiahua Pan, Baijun Dong, Wei Xue

Cancer Res Treat. 2023;55(3):969-977. Published online March 2, 2023 DOI: https://doi.org/10.4143/crt.2022.1557

Web of Science 1 Crossref 1

Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers

Yongjun Cha, Sheehyun Kim, Sae-Won Han

Cancer Res Treat. 2023;55(2):367-384. DOI: https://doi.org/10.4143/crt.2023.446

Web of Science 2

Clinical Circulating Tumor DNA Testing for Precision Oncology

Hyunji Kim, Kyoung Un Park

Cancer Res Treat. 2023;55(2):351-366. DOI: https://doi.org/10.4143/crt.2022.1026

Web of Science 6 Crossref 7

Hematologic malignancy

Circulating Tumor DNA–Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas

Seok Jin Kim, Yeon Jeong Kim, Sang Eun Yoon, Kyung Ju Ryu, Bon Park, Donghyun Park, Duck Cho, Hyun-Young Kim, Junhun Cho, Young Hyeh Ko, Woong-Yang Park, Won Seog Kim

Cancer Res Treat. 2023;55(1):291-303. Published online March 2, 2022 DOI: https://doi.org/10.4143/crt.2022.017

Web of Science 4 Crossref 4

Lung and Thoracic cancer

The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer

Yu Feng, Yutao Liu, Mingming Yuan, Guilan Dong, Hongxia Zhang, Tongmei Zhang, Lianpeng Chang, Xuefeng Xia, Lifeng Li, Haohua Zhu, Puyuan Xing, Hongyu Wang, Yuankai Shi, Zhijie Wang, Xingsheng Hu

Cancer Res Treat. 2022;54(3):753-766. Published online October 5, 2021 DOI: https://doi.org/10.4143/crt.2021.905

Web of Science 3 Crossref 3

Hematologic malignancy

Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma

Sang Eun Yoon, Yeon Jeong Kim, Joon Ho Shim, Donghyun Park, Junhun Cho, Young Hyeh Ko, Woong-Yang Park, Yeung-Chul Mun, Kyoung Eun Lee, Duck Cho, Won Seog Kim, Seok Jin Kim

Cancer Res Treat. 2022;54(2):597-612. Published online July 23, 2021 DOI: https://doi.org/10.4143/crt.2021.752

Web of Science 6 Crossref 6

Lung cancer

A Phase II Trial of Osimertinib as the First-Line Treatment of Non–Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1

Cheol-Kyu Park, Hyun-Ju Cho, Yoo-Duk Choi, In-Jae Oh, Young-Chul Kim

Cancer Res Treat. 2021;53(1):93-103. Published online September 21, 2020 DOI: https://doi.org/10.4143/crt.2020.459

Web of Science 2 Crossref 3

Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer

Mi-Ryung Han, Sug Hyung Lee, Jung Yoon Park, Hyosun Hong, Jung Yoon Ho, Soo Young Hur, Youn Jin Choi

Cancer Res Treat. 2020;52(3):779-788. Published online February 28, 2020 DOI: https://doi.org/10.4143/crt.2019.700

Web of Science 22 Crossref 23

A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2

Cheol-Kyu Park, Hyun-Ju Cho, Yoo-Duk Choi, In-Jae Oh, Young-Chul Kim

Cancer Res Treat. 2019;51(2):777-787. Published online September 7, 2018 DOI: https://doi.org/10.4143/crt.2018.387

Web of Science 40 Crossref 36

Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in NSCLC

Hanbaek Yi, Jeonghwan Youk, Yoojoo Lim, Hanseong Roh, Dongsoo Roh, Dongsoo Kyung, Hwang-Phill Kim, Duhee Bang, Bhumsuk Keam, Tae-Min Kim, Miso Kim, Dong-Wan Kim, Tae-You Kim

Received December 7, 2023 Accepted January 8, 2024 Published online January 8, 2024
DOI: https://doi.org/10.4143/crt.2023.1294
[Accepted]

Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma

Sang Eun Yoon, Seung-Ho Shin, Dae Keun Nam, Junhun Cho, Won Seog Kim, Seok Jin Kim

Received July 23, 2023 Accepted January 15, 2024 Published online January 16, 2024
DOI: https://doi.org/10.4143/crt.2023.869
[Accepted]